PGRPLC (AGAP005203) is a transmembrane peptidoglycan recognition protein (PGRP) that serves as the principal upstream receptor for the IMD (Immune Deficiency) signaling pathway in Anopheles gambiae. It is the ortholog of Drosophila PGRP-LC. Despite containing an amidase_2 superfamily domain, PGRPLC functions as a NON-CATALYTIC pattern recognition receptor that binds DAP-type peptidoglycan from bacterial cell walls to initiate innate immune signaling. Three main isoforms (LC1, LC2, LC3) arise from alternative splicing and show distinct ligand binding properties: LC1 and LC3 bind polymeric DAP-PGN, while LC2 forms complexes with LC3 in the presence of monomeric TCT muropeptides. PGRPLC-mediated activation of the REL2/NF-kB pathway induces antimicrobial peptide expression, controls gut microbiota homeostasis, and indirectly modulates Plasmodium infection intensity in this malaria vector species.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005615
extracellular space
|
IBA
GO_REF:0000033 |
MODIFY |
Summary: The IBA annotation for extracellular space is propagated from Drosophila PGRP-LC orthologs and human PGRPs. However, Anopheles PGRPLC is a transmembrane receptor with a single transmembrane helix (residues 218-241 per UniProt) and the PGRP domain is located C-terminal to this transmembrane region, indicating the receptor domain faces extracellularly. The protein is membrane-anchored, not secreted into the extracellular space.
Reason: PGRPLC is a type I transmembrane protein based on UniProt domain annotation showing a transmembrane helix at positions 218-241 and the PGRP domain at 280-425. The deep research (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md) confirms it is localized to the "Epithelial plasma membrane of the midgut". The annotation should reflect plasma membrane localization, not extracellular space which implies a secreted/soluble form.
Proposed replacements:
plasma membrane
Supporting Evidence:
file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
Functional analyses localize PGRPLC activity to the midgut epithelium with regionalized expression
|
|
GO:0006955
immune response
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: PGRPLC is firmly established as an immune receptor that initiates the innate immune response against bacterial pathogens in Anopheles gambiae. RNAi knockdown experiments demonstrate increased mortality upon bacterial challenge and impaired antimicrobial peptide induction (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md).
Reason: This is a well-supported core function. The deep research establishes that PGRPLC knockdown "decreased survival - E. coli, 50% mortality by day 4; S. aureus, 50% by day 2 and near-complete by day 6" and impairs AMP induction. The term 'immune response' accurately captures the general biological process.
Supporting Evidence:
file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
Systemic antibacterial challenge survival (RNAi PGRPLC): Whole-gene KD decreased survival - E. coli, 50% mortality by day 4; S. aureus, 50% by day 2 and near-complete by day 6 (both P<0.001)
|
|
GO:0008745
N-acetylmuramoyl-L-alanine amidase activity
|
IBA
GO_REF:0000033 |
REMOVE |
Summary: This is an OVER-ANNOTATION. While PGRPLC contains an amidase_2 superfamily domain (IPR002502), the literature explicitly states that PGRP-LC functions as a non-catalytic pattern recognition receptor in insects. The amidase fold is used for peptidoglycan binding and receptor dimerization, NOT for enzymatic hydrolysis.
Reason: The deep research (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md) explicitly states: "Despite the amidase fold, PGRP-LC functions as a non-catalytic pattern-recognition receptor in mosquitoes (structural alignment/modeling; no amidase activity reported)". OpenScientist independently found that PGRPLC lacks two of the three zinc-binding residues required for PGRP amidase catalysis (H310A and C429S relative to catalytic PGRPs). The fetched GOA line shows live IBA propagation through PANTHER:PTN002475783 from a mixed PGRP source set; this should not be retained for the non-catalytic receptor PGRP-LC subfamily. The correct molecular function is peptidoglycan immune receptor activity (GO:0016019).
Propagation Review
Root cause:
PROPAGATION BAD
Failure modes:
PSEUDO OR SUBACTIVITY LOSS
SOURCE EVIDENCE WEAK
Sources checked:
PANTHER:PTN002475783
· PAINT PGRP amidase source node
SUPPORTS SOURCE BUT NOT TARGET
The fetched GOA line propagates GO:0008745 through this node, but PGRPLC is a non-catalytic PGRP-LC receptor and lacks the zinc-ligand residue set needed for amidase catalysis.
Supporting Evidence:
file:ANOGA/PGRPLC/PGRPLC-goa.tsv
UniProtKB A7UTA1 PGRPLC enables GO:0008745 N-acetylmuramoyl-L-alanine amidase activity molecular_function ECO:0000318 IBA GO_REF:0000033 FB:FBgn0033327|FB:FBgn0037906|FB:FBgn0043578|PANTHER:PTN002475783|UniProtKB:Q96PD5|ZFIN:ZDB-GENE-050419-71|ZFIN:ZDB-GENE-071227-1|ZFIN:ZDB-GENE-071227-2 7165 Anopheles gambiae GO_Central AGAP005203-PC 20250731
file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
Despite the amidase fold, PGRP-LC functions as a non-catalytic pattern-recognition receptor in mosquitoes (structural alignment/modeling; no amidase activity reported)
file:ANOGA/PGRPLC/PGRPLC-hypotheses/function-hypothesis-go-0008745/openscientist.md
PGRPLC lacks two of the three zinc-binding residues absolutely required for amidase catalysis
file:ANOGA/PGRPLC/PGRPLC-hypotheses/function-hypothesis-go-0008745/openscientist.md
The current annotation of GO:0008745 (N-acetylmuramoyl-L-alanine amidase activity) with IBA evidence should be **removed** from A7UTA1.
|
|
GO:0016019
peptidoglycan immune receptor activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: This is the CORRECT and PRIMARY molecular function annotation for PGRPLC. It accurately describes the protein as a peptidoglycan recognition receptor that initiates immune signaling upon ligand binding.
Reason: The deep research (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md) confirms PGRPLC as the "Transmembrane pattern-recognition receptor of the IMD/REL2 pathway" that "Recognizes DAP-type PGN ligands in both polymeric (bacterial sacculus) and monomeric (TCT-like) forms via isoform assemblies." Pull-down assays demonstrate direct peptidoglycan binding by PGRPLC isoforms. This is the core molecular function term for this protein.
Supporting Evidence:
file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
Ligand specificity: PGRPLC discriminates between polymeric DAP-type PGN and monomeric muropeptides (TCT). In pull-down assays, LC1 and LC3 bind insoluble polymeric DAP-PGN, while LC2 forms complexes with LC3 in the presence of TCT monomer
|
|
GO:0050830
defense response to Gram-positive bacterium
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: PGRPLC is primarily known as a receptor for DAP-type peptidoglycan, which is characteristic of Gram-negative bacteria and Bacillus species. However, experimental evidence shows PGRPLC-dependent survival and AMP induction against S. aureus (Gram-positive).
Reason: The deep research (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md) shows PGRPLC knockdown causes mortality after S. aureus challenge: "S. aureus, 50% by day 2 and near-complete by day 6." However, the primary recognized ligand is DAP-type PGN from Gram-negative bacteria. Gram-positive bacteria like S. aureus contain Lys-type PGN, not DAP-type. The defense response may be indirect or involve cross-reactivity. PGRPLC's canonical role is in sensing Gram-negative bacteria through the IMD pathway. A more appropriate annotation would be defense response to Gram-negative bacterium (GO:0050829), but the existing annotation is not wrong as PGRPLC does contribute to Gram-positive defense.
Supporting Evidence:
file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
Systemic antibacterial challenge survival: S. aureus, 50% by day 2 and near-complete by day 6 (both P<0.001)
|
|
GO:0002376
immune system process
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: This IEA annotation from UniProtKB keyword mapping is a broad parent term of the more specific immune response annotation. It is not wrong but is less informative than the existing IBA annotation for immune response.
Reason: The annotation is correct as PGRPLC participates in immune system processes. However, the more specific 'immune response' (GO:0006955) annotation is preferred for capturing the gene's function. This broader term can be retained as it does not conflict and provides a valid hierarchical annotation.
Supporting Evidence:
file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
PGRP-LC-driven sensing in the gut is particularly important for antibacterial defense
|
|
GO:0008270
zinc ion binding
|
IEA
GO_REF:0000002 |
UNDECIDED |
Summary: This IEA annotation is based on InterPro domain IPR006619 (PGRP domain). The PGRP domain structure in catalytic family members coordinates a zinc ion essential for amidase activity. However, since PGRPLC is non-catalytic, the zinc binding function may not be relevant.
Reason: The InterPro PGRP domain annotation (IPR006619) suggests potential zinc binding based on structural homology to catalytic PGRPs. However, the deep research (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md) explicitly states PGRPLC is non-catalytic and "no amidase activity reported." Catalytic PGRPs require zinc for amidase activity, but non-catalytic PGRPs may have lost critical zinc-coordinating residues. Without specific structural data for Anopheles PGRPLC showing zinc coordination, this annotation remains uncertain.
Supporting Evidence:
file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
Despite the amidase fold, PGRP-LC functions as a non-catalytic pattern-recognition receptor
|
|
GO:0008745
N-acetylmuramoyl-L-alanine amidase activity
|
IEA
GO_REF:0000002 |
REMOVE |
Summary: This is the same over-annotation as the IBA version, but derived from InterPro domain mapping instead of phylogenetic inference. PGRPLC does NOT have amidase activity.
Reason: Same rationale as for the IBA annotation above. The InterPro domains (IPR002502, IPR006619, IPR036505) are structural domains that can be present in both catalytic and non-catalytic PGRPs. PGRPLC uses this fold for peptidoglycan binding and receptor function, NOT for enzymatic hydrolysis. The literature explicitly confirms this is a non-catalytic receptor PGRP (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md).
Supporting Evidence:
file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
It is not an active amidase enzyme; rather, it uses a PGRP/amidase_2 structural fold for ligand binding and receptor dimerization to initiate signaling
|
|
GO:0009253
peptidoglycan catabolic process
|
IEA
GO_REF:0000002 |
REMOVE |
Summary: This annotation implies PGRPLC degrades peptidoglycan, which is incorrect. PGRPLC binds peptidoglycan as a receptor ligand but does not catabolize it.
Reason: This annotation is a logical consequence of the incorrect amidase activity annotation. Since PGRPLC is a non-catalytic receptor, it does not participate in peptidoglycan catabolism. It binds peptidoglycan to initiate signaling, but binding is not catabolism. The correct process annotation is the peptidoglycan recognition protein signaling pathway (GO:0061057) or immune response (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md).
Supporting Evidence:
file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
It uses a PGRP/amidase_2 structural fold for ligand binding and receptor dimerization to initiate signaling
|
|
GO:0045087
innate immune response
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: This annotation accurately captures that PGRPLC functions in innate immunity. It is more specific than 'immune system process' and appropriately describes the non-adaptive immune function of this receptor.
Reason: The deep research (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md) and multiple publications confirm PGRPLC as the canonical innate immune receptor for the IMD pathway in mosquitoes. The term is appropriate and well-supported by experimental evidence showing PGRPLC initiates innate immune responses including AMP production and defense against bacteria.
Supporting Evidence:
file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
PGRPLC is the principal transmembrane receptor that activates the mosquito IMD/REL2 NF-kB pathway, leading to induction of antimicrobial peptide (AMP) genes
|
|
GO:0061057
peptidoglycan recognition protein signaling pathway
|
TAS
file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md |
NEW |
Summary: PGRPLC is the initiating receptor for the peptidoglycan recognition protein (IMD) signaling pathway. This is a missing core process annotation.
Reason: The deep research (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md) explicitly states PGRPLC is "Upstream PRR of the mosquito IMD pathway, activating REL2/NF-kB to induce AMPs." The GO term GO:0061057 explicitly describes this pathway with definition: "The series of molecular signals initiated by binding of peptidoglycan to a receptor and ending with regulation of a downstream cellular process. The main outcome of the Imd signaling is the production of antimicrobial peptides." This is the most specific and appropriate process term for PGRPLC.
Supporting Evidence:
file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
PGRPLC is the principal transmembrane receptor that activates the mosquito IMD/REL2 NF-kB pathway
|
|
GO:0050829
defense response to Gram-negative bacterium
|
TAS
file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md |
NEW |
Summary: PGRPLC specifically recognizes DAP-type peptidoglycan, which is characteristic of Gram-negative bacteria. This is the primary defense response mediated by PGRPLC.
Reason: The deep research (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md) confirms "Substrate specificity: Discriminates DAP-type PGN." DAP-type peptidoglycan is the signature cell wall component of Gram-negative bacteria. PGRPLC knockdown increases susceptibility to E. coli (Gram-negative) and also affects Plasmodium infection through gut microbiota control (primarily Gram-negative in mosquito gut). This term complements the existing Gram-positive annotation and is arguably more central to PGRPLC function.
Supporting Evidence:
file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
Substrate specificity: Discriminates DAP-type PGN. LC1/LC3 bind polymeric DAP-PGN
|
|
GO:0042834
peptidoglycan binding
|
IDA
file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md |
NEW |
Summary: Biochemical pull-down assays demonstrate direct binding of PGRPLC isoforms to peptidoglycan ligands, supporting a peptidoglycan binding annotation.
Reason: The deep research (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md) reports: "Biochemical ligand interactions: Co-precipitation shows LC1 and LC3 bind insoluble polymeric DAP-type PGN; LC2 forms complexes with LC3 in the presence of the monomeric muropeptide TCT." This is direct experimental evidence for peptidoglycan binding activity. While peptidoglycan immune receptor activity (GO:0016019) encompasses this function, peptidoglycan binding (GO:0042834) is an appropriate supporting annotation for the binding activity itself.
Supporting Evidence:
file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
Co-precipitation shows LC1 and LC3 bind insoluble polymeric DAP-type PGN; LC2 forms complexes with LC3 in the presence of the monomeric muropeptide TCT
|
Q: Has the catalytic site residue status been experimentally verified for An. gambiae PGRPLC, confirming it lacks amidase activity?
Q: What is the three-dimensional structure of PGRPLC PGRP domain and how does it compare to catalytic vs non-catalytic PGRP structures?
Q: Does PGRPLC coordinate zinc, and if so, what is its functional role in ligand binding?
Experiment: Recombinant expression and biochemical assay to definitively confirm absence of amidase activity
Hypothesis: PGRPLC lacks amidase activity due to non-catalytic residues in the active site
Experiment: Crystal or cryo-EM structure determination of PGRPLC PGRP domain with and without PGN ligand
Hypothesis: PGRPLC PGRP domain adopts receptor conformation distinct from catalytic PGRPs
Experiment: Metal binding analysis (ITC, ICP-MS) to determine zinc coordination status
Hypothesis: PGRPLC may or may not coordinate zinc depending on retention of zinc-binding residues
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Research plan status: All objectives completed; composing the final report.
Gene/protein identity verification
PGRPLC is the Anopheles gambiae ortholog of Drosophila PGRP-LC and corresponds to AGAP005203; it encodes a transmembrane peptidoglycan-recognition receptor with a PGRP/amidase_2-fold domain. Alternative splicing yields three principal isoforms (PGRPLC1/2/3). This mapping and isoform architecture are documented for An. gambiae/coluzzii midgut and link directly to IMD/REL2 signaling (Insect Biochemistry and Molecular Biology, 2020; DOI:10.1016/j.ibmb.2019.103288) (rodgers2020functionalanalysisof pages 1-3, rodgers2020functionalanalysisof pages 3-6, rodgers2020functionalanalysisof pages 10-12). Foundational functional work in An. gambiae established PGRP-LC as the IMD-pathway receptor controlling antibacterial defense, gut bacterial homeostasis, and Plasmodium infection intensity (PLoS Pathogens, 2009; DOI:10.1371/journal.ppat.1000542) (meister2009anophelesgambiaepgrplcmediated pages 1-2, meister2009anophelesgambiaepgrplcmediated pages 2-4, meister2009anophelesgambiaepgrplcmediated pages 9-9).
1) Key concepts and definitions
- Molecular identity and domain architecture: PGRPLC (AGAP005203; UniProt A7UTA1) encodes a membrane receptor bearing an extracellular PGRP domain of the amidase_2 superfamily that recognizes peptidoglycan (PGN). Despite the amidase fold, PGRP-LC functions as a non-catalytic pattern-recognition receptor in mosquitoes (structural alignment/modeling; no amidase activity reported) (PLoS Pathogens, 2009; DOI:10.1371/journal.ppat.1000542) (meister2009anophelesgambiaepgrplcmediated pages 11-12, meister2009anophelesgambiaepgrplcmediated pages 10-11).
- Isoforms and receptor assembly: Three main isoforms (LC1/LC2/LC3) arise by alternative splicing and differ in their PGRP ectodomains. LC3 contains a two-residue insertion predicted to prevent it from initiating dimerization; modeling supports a role for LC3 in sequestering monomeric PGN under low-dose conditions and stabilizing signaling heterodimers under high-dose conditions (PLoS Pathogens, 2009; DOI:10.1371/journal.ppat.1000542) (meister2009anophelesgambiaepgrplcmediated pages 9-9, meister2009anophelesgambiaepgrplcmediated pages 11-12).
- Ligand specificity: PGRPLC discriminates between polymeric DAP-type PGN and monomeric muropeptides (TCT). In pull-down assays, LC1 and LC3 bind insoluble polymeric DAP-PGN, while LC2 forms complexes with LC3 in the presence of TCT monomer, indicating isoform-dependent sensing of distinct PGN forms (Insect Biochemistry and Molecular Biology, 2020; DOI:10.1016/j.ibmb.2019.103288) (rodgers2020functionalanalysisof pages 10-12, rodgers2020functionalanalysisof pages 6-8).
- Signaling pathway: PGRPLC is the principal transmembrane receptor that activates the mosquito IMD/REL2 NF-κB pathway, leading to induction of antimicrobial peptide (AMP) genes and bacterial control. Anopheles lacks PGRP-LE; thus, PGRP-LC-driven sensing in the gut is particularly important (IBMB 2020; PLoS Pathog 2009) (rodgers2020functionalanalysisof pages 1-3, rodgers2020functionalanalysisof pages 3-6, meister2009anophelesgambiaepgrplcmediated pages 1-2).
- Cellular/tissue localization: Functional analyses localize PGRPLC activity to the midgut epithelium with regionalized expression—PGRPLC1 enriched in cardia/anterior midgut; PGRPLC2/3 more uniform; REL2-responsive AMPs (GAM1, CEC1, LYSC1) show distinct regional patterns (IBMB 2020; DOI above) (rodgers2020functionalanalysisof pages 10-12, rodgers2020functionalanalysisof pages 12-17).
2) Recent developments and latest research (2023–2024 priority)
- Contemporary expert reviews emphasize PGRP-LC as the canonical IMD receptor in mosquitoes, integrating microbiota control with gut compartmentalization of AMPs and tolerance mechanisms (Philosophical Transactions B, 2024; DOI:10.1098/rstb.2023.0063) (hixson2024innateimmunityin pages 9-10). Parasites & Vectors (2024) reviews position cecropins, gambicins, and lysozymes under IMD/Toll control and outline their roles against bacteria and Plasmodium (DOI:10.1186/s13071-024-06161-4) (li2024responseofthe pages 10-11). A 2024 IMD/AMP review also reaffirms PGRP-LC/LE sensing of DAP-PGN to drive NF-κB–dependent AMPs (IJMS, 2024; DOI:10.3390/ijms25073835) (zhou2024insectantimicrobialpeptides pages 9-10).
- New mechanistic links to peritrophic matrix (PM): Recent work shows bacterial cell wall components (e.g., DAP-PGN, Lys-PGN, LPS) can stimulate PM formation through IMD activation; knockdown of PGRP-LC or REL2 reduces Per1 transcription and PM integrity in mosquitoes, implicating PGRP-LC–IMD in PM homeostasis and, by extension, parasite invasion barriers (PLOS Biology, 2025; DOI:10.1371/journal.pbio.3002967) (song2025cellwallcomponents pages 18-19).
3) Current applications and real-world implementations
- Vector competence modulation: RNAi silencing of PGRPLC increases Plasmodium infection intensities and prevalence (P. berghei and P. falciparum), demonstrating that modulating PGRP-LC–IMD signaling can alter malaria transmission potential. This positions PGRP-LC pathway components as candidate targets in genetic or microbial interventions to reduce vector competence by rebalancing gut microbiota and strengthening epithelial defenses (PLoS Pathog, 2009; DOI:10.1371/journal.ppat.1000542) (meister2009anophelesgambiaepgrplcmediated pages 4-5).
- Gut microbiota homeostasis/PM engineering: Given PGRP-LC’s role in controlling post-bloodmeal bacterial expansion and in promoting PM formation via IMD, manipulating PGRP-LC signaling could reinforce the PM barrier or microbiota composition to impair Plasmodium development (PLOS Biology, 2025; DOI:10.1371/journal.pbio.3002967) (song2025cellwallcomponents pages 18-19) and is consistent with 2024 reviews on gut immune zonation (Philosophical Transactions B, 2024; DOI:10.1098/rstb.2023.0063) (hixson2024innateimmunityin pages 9-10).
4) Expert opinions and analysis
- Consensus across 2024 reviews underscores PGRP-LC as the central IMD receptor in mosquitoes, with compartmentalized expression and downstream AMP programs shaping symbiont control and pathogen resistance (Philosophical Transactions B, 2024; Parasites & Vectors, 2024; IJMS, 2024) (hixson2024innateimmunityin pages 9-10, li2024responseofthe pages 10-11, zhou2024insectantimicrobialpeptides pages 9-10). These analyses align with functional and biochemical isoform specificity established in Anopheles (IBMB 2020) and foundational An. gambiae genetics (PLoS Pathog 2009) (rodgers2020functionalanalysisof pages 10-12, meister2009anophelesgambiaepgrplcmediated pages 1-2).
5) Relevant statistics and data from recent studies
- Systemic antibacterial challenge survival (RNAi PGRPLC): Whole-gene KD decreased survival—E. coli, 50% mortality by day 4; S. aureus, 50% by day 2 and near-complete by day 6 (both P<0.001). Isoform KD: LC3 KD led to 50% mortality by day 2 (E. coli) and day 1 (S. aureus); LC1/LC2 KDs gave 40–50% mortality by day 6 (P≤0.05) (PLoS Pathog, 2009; DOI:10.1371/journal.ppat.1000542) (meister2009anophelesgambiaepgrplcmediated pages 4-5, meister2009anophelesgambiaepgrplcmediated pages 2-4).
- AMP induction after infection: At 3 h, CEC1 increased 4–5-fold and DEF1 2–3-fold; induction required PGRPLC for S. aureus but not for E. coli (PLoS Pathog, 2009) (meister2009anophelesgambiaepgrplcmediated pages 4-5).
- Midgut microbiota expansion: After a bloodmeal, gut bacteria expand by up to several thousand-fold, coincident with robust PGRPLC-mediated AMP induction (PLoS Pathog, 2009) (meister2009anophelesgambiaepgrplcmediated pages 9-9).
- Plasmodium infection outcomes: Whole PGRPLC KD increased P. berghei median oocysts 4.4-fold (P<0.001) and elevated P. falciparum prevalence from 41% to 52% with higher median intensity (P<0.005) (PLoS Pathog, 2009) (meister2009anophelesgambiaepgrplcmediated pages 4-5).
- Gut regionalization and isoform-specific AMP control (midgut): REL2 KD reduced GAM1 across regions (p<0.05) and LYSC1 in cardia (p=0.05) and anterior (p<0.05). PGRPLC1 KD increased GAM1 in anterior (p<0.05). PGRPLC2 KD reduced GAM1 in cardia/anterior (p<0.05), reduced LYSC1 in posterior (p<0.05), and reduced CEC1 in cardia (p<0.05). PGRPLC3 KD reduced LYSC1 in cardia (p<0.05) and posterior (p<0.01) (IBMB, 2020; DOI:10.1016/j.ibmb.2019.103288) (rodgers2020functionalanalysisof pages 10-12, rodgers2020functionalanalysisof pages 6-8).
- Biochemical ligand interactions: Co-precipitation shows LC1 and LC3 bind insoluble polymeric DAP-type PGN; LC2 forms complexes with LC3 in the presence of the monomeric muropeptide TCT (IBMB, 2020) (rodgers2020functionalanalysisof pages 10-12, rodgers2020functionalanalysisof pages 6-8).
Functional annotation synthesis for PGRPLC (AGAP005203; UniProt A7UTA1)
- Primary function: Transmembrane pattern-recognition receptor of the IMD/REL2 pathway. Recognizes DAP-type PGN ligands in both polymeric (bacterial sacculus) and monomeric (TCT-like) forms via isoform assemblies. It is not an active amidase enzyme; rather, it uses a PGRP/amidase_2 structural fold for ligand binding and receptor dimerization to initiate signaling (PLoS Pathog, 2009; IBMB, 2020) (meister2009anophelesgambiaepgrplcmediated pages 11-12, rodgers2020functionalanalysisof pages 10-12).
- Substrate specificity: Discriminates DAP-type PGN. LC1/LC3 bind polymeric DAP-PGN; LC2 associates with LC3 in the presence of TCT, suggesting LC2 contributes to monomeric muropeptide sensing (IBMB, 2020) (rodgers2020functionalanalysisof pages 10-12, rodgers2020functionalanalysisof pages 6-8).
- Cellular localization and site of action: Epithelial plasma membrane of the midgut, with region-specific expression patterns and downstream regulation of REL2-responsive AMPs; systemic roles also evidenced by survival phenotypes after hemolymph bacterial challenge (IBMB, 2020; PLoS Pathog, 2009) (rodgers2020functionalanalysisof pages 10-12, meister2009anophelesgambiaepgrplcmediated pages 2-4).
- Pathway placement: Upstream PRR of the mosquito IMD pathway, activating REL2/NF-κB to induce AMPs (e.g., CECs, GAM1, LYSC1) and shape gut bacterial homeostasis and peritrophic matrix regulation, indirectly constraining Plasmodium development (Philosophical Transactions B, 2024; Parasites & Vectors, 2024; PLoS Pathog, 2009; PLOS Biology, 2025) (hixson2024innateimmunityin pages 9-10, li2024responseofthe pages 10-11, meister2009anophelesgambiaepgrplcmediated pages 4-5, song2025cellwallcomponents pages 18-19).
Notes on symbol ambiguity check
No conflicting gene symbol usage for PGRPLC in Anopheles gambiae was found in the collected literature; the locus consistently maps to AGAP005203 and encodes the PGRP-LC IMD receptor with the described isoforms (IBMB, 2020; PLoS Pathog, 2009) (rodgers2020functionalanalysisof pages 1-3, meister2009anophelesgambiaepgrplcmediated pages 2-4).
Data availability: URLs and dates
- Meister et al., 2009, PLoS Pathogens, “Anopheles gambiae PGRPLC-Mediated Defense against Bacteria Modulates Infections with Malaria Parasites,” published Aug 2009. URL: https://doi.org/10.1371/journal.ppat.1000542 (meister2009anophelesgambiaepgrplcmediated pages 1-2, meister2009anophelesgambiaepgrplcmediated pages 2-4, meister2009anophelesgambiaepgrplcmediated pages 9-9, meister2009anophelesgambiaepgrplcmediated pages 4-5, meister2009anophelesgambiaepgrplcmediated pages 9-10).
- Rodgers et al., 2020, Insect Biochemistry and Molecular Biology, “Functional analysis of the three major PGRPLC isoforms in the midgut of the malaria mosquito Anopheles coluzzii,” published Mar 2020. URL: https://doi.org/10.1016/j.ibmb.2019.103288 (rodgers2020functionalanalysisof pages 1-3, rodgers2020functionalanalysisof pages 3-6, rodgers2020functionalanalysisof pages 12-17, rodgers2020functionalanalysisof pages 10-12, rodgers2020functionalanalysisof pages 6-8).
- Hixson et al., 2024, Philosophical Transactions of the Royal Society B, “Innate immunity in Aedes mosquitoes: from pathogen resistance to shaping the microbiota,” published Mar 2024. URL: https://doi.org/10.1098/rstb.2023.0063 (hixson2024innateimmunityin pages 9-10).
- Li et al., 2024, Parasites & Vectors, “Response of the mosquito immune system and symbiotic bacteria to pathogen infection,” published Feb 2024. URL: https://doi.org/10.1186/s13071-024-06161-4 (li2024responseofthe pages 10-11).
- Zhou et al., 2024, International Journal of Molecular Sciences, “Insect Antimicrobial Peptides as Guardians of Immunity and Beyond: A Review,” published Mar 2024. URL: https://doi.org/10.3390/ijms25073835 (zhou2024insectantimicrobialpeptides pages 9-10).
- Song et al., 2025, PLOS Biology, “Cell wall components of gut commensal bacteria stimulate peritrophic matrix formation in malaria vector mosquitoes through activation of the IMD pathway,” published Jan 2025. URL: https://doi.org/10.1371/journal.pbio.3002967 (song2025cellwallcomponents pages 18-19).
References
(rodgers2020functionalanalysisof pages 1-3): Faye H. Rodgers, Julia A. Cai, Andre N. Pitaluga, Dominique Mengin-Lecreulx, Mathilde Gendrin, and George K. Christophides. Functional analysis of the three major pgrplc isoforms in the midgut of the malaria mosquito anopheles coluzzii. Insect Biochemistry and Molecular Biology, 118:103288, Mar 2020. URL: https://doi.org/10.1016/j.ibmb.2019.103288, doi:10.1016/j.ibmb.2019.103288. This article has 11 citations and is from a peer-reviewed journal.
(rodgers2020functionalanalysisof pages 3-6): Faye H. Rodgers, Julia A. Cai, Andre N. Pitaluga, Dominique Mengin-Lecreulx, Mathilde Gendrin, and George K. Christophides. Functional analysis of the three major pgrplc isoforms in the midgut of the malaria mosquito anopheles coluzzii. Insect Biochemistry and Molecular Biology, 118:103288, Mar 2020. URL: https://doi.org/10.1016/j.ibmb.2019.103288, doi:10.1016/j.ibmb.2019.103288. This article has 11 citations and is from a peer-reviewed journal.
(rodgers2020functionalanalysisof pages 10-12): Faye H. Rodgers, Julia A. Cai, Andre N. Pitaluga, Dominique Mengin-Lecreulx, Mathilde Gendrin, and George K. Christophides. Functional analysis of the three major pgrplc isoforms in the midgut of the malaria mosquito anopheles coluzzii. Insect Biochemistry and Molecular Biology, 118:103288, Mar 2020. URL: https://doi.org/10.1016/j.ibmb.2019.103288, doi:10.1016/j.ibmb.2019.103288. This article has 11 citations and is from a peer-reviewed journal.
(meister2009anophelesgambiaepgrplcmediated pages 1-2): Stephan Meister, Bogos Agianian, Fanny Turlure, Angela Relógio, Isabelle Morlais, Fotis C. Kafatos, and George K. Christophides. Anopheles gambiae pgrplc-mediated defense against bacteria modulates infections with malaria parasites. PLoS Pathogens, 5:e1000542, Aug 2009. URL: https://doi.org/10.1371/journal.ppat.1000542, doi:10.1371/journal.ppat.1000542. This article has 290 citations and is from a highest quality peer-reviewed journal.
(meister2009anophelesgambiaepgrplcmediated pages 2-4): Stephan Meister, Bogos Agianian, Fanny Turlure, Angela Relógio, Isabelle Morlais, Fotis C. Kafatos, and George K. Christophides. Anopheles gambiae pgrplc-mediated defense against bacteria modulates infections with malaria parasites. PLoS Pathogens, 5:e1000542, Aug 2009. URL: https://doi.org/10.1371/journal.ppat.1000542, doi:10.1371/journal.ppat.1000542. This article has 290 citations and is from a highest quality peer-reviewed journal.
(meister2009anophelesgambiaepgrplcmediated pages 9-9): Stephan Meister, Bogos Agianian, Fanny Turlure, Angela Relógio, Isabelle Morlais, Fotis C. Kafatos, and George K. Christophides. Anopheles gambiae pgrplc-mediated defense against bacteria modulates infections with malaria parasites. PLoS Pathogens, 5:e1000542, Aug 2009. URL: https://doi.org/10.1371/journal.ppat.1000542, doi:10.1371/journal.ppat.1000542. This article has 290 citations and is from a highest quality peer-reviewed journal.
(meister2009anophelesgambiaepgrplcmediated pages 11-12): Stephan Meister, Bogos Agianian, Fanny Turlure, Angela Relógio, Isabelle Morlais, Fotis C. Kafatos, and George K. Christophides. Anopheles gambiae pgrplc-mediated defense against bacteria modulates infections with malaria parasites. PLoS Pathogens, 5:e1000542, Aug 2009. URL: https://doi.org/10.1371/journal.ppat.1000542, doi:10.1371/journal.ppat.1000542. This article has 290 citations and is from a highest quality peer-reviewed journal.
(meister2009anophelesgambiaepgrplcmediated pages 10-11): Stephan Meister, Bogos Agianian, Fanny Turlure, Angela Relógio, Isabelle Morlais, Fotis C. Kafatos, and George K. Christophides. Anopheles gambiae pgrplc-mediated defense against bacteria modulates infections with malaria parasites. PLoS Pathogens, 5:e1000542, Aug 2009. URL: https://doi.org/10.1371/journal.ppat.1000542, doi:10.1371/journal.ppat.1000542. This article has 290 citations and is from a highest quality peer-reviewed journal.
(rodgers2020functionalanalysisof pages 6-8): Faye H. Rodgers, Julia A. Cai, Andre N. Pitaluga, Dominique Mengin-Lecreulx, Mathilde Gendrin, and George K. Christophides. Functional analysis of the three major pgrplc isoforms in the midgut of the malaria mosquito anopheles coluzzii. Insect Biochemistry and Molecular Biology, 118:103288, Mar 2020. URL: https://doi.org/10.1016/j.ibmb.2019.103288, doi:10.1016/j.ibmb.2019.103288. This article has 11 citations and is from a peer-reviewed journal.
(rodgers2020functionalanalysisof pages 12-17): Faye H. Rodgers, Julia A. Cai, Andre N. Pitaluga, Dominique Mengin-Lecreulx, Mathilde Gendrin, and George K. Christophides. Functional analysis of the three major pgrplc isoforms in the midgut of the malaria mosquito anopheles coluzzii. Insect Biochemistry and Molecular Biology, 118:103288, Mar 2020. URL: https://doi.org/10.1016/j.ibmb.2019.103288, doi:10.1016/j.ibmb.2019.103288. This article has 11 citations and is from a peer-reviewed journal.
(hixson2024innateimmunityin pages 9-10): Bretta Hixson, Robin Chen, and Nicolas Buchon. Innate immunity in aedes mosquitoes: from pathogen resistance to shaping the microbiota. Philosophical Transactions of the Royal Society B: Biological Sciences, Mar 2024. URL: https://doi.org/10.1098/rstb.2023.0063, doi:10.1098/rstb.2023.0063. This article has 14 citations and is from a domain leading peer-reviewed journal.
(li2024responseofthe pages 10-11): Manjin Li, Yang Zhou, Jin Cheng, Yiqing Wang, Cejie Lan, and Yuan Shen. Response of the mosquito immune system and symbiotic bacteria to pathogen infection. Parasites & Vectors, Feb 2024. URL: https://doi.org/10.1186/s13071-024-06161-4, doi:10.1186/s13071-024-06161-4. This article has 35 citations and is from a peer-reviewed journal.
(zhou2024insectantimicrobialpeptides pages 9-10): Lizhen Zhou, Guanliang Meng, Ling Zhu, Li Ma, and Kangkang Chen. Insect antimicrobial peptides as guardians of immunity and beyond: a review. International Journal of Molecular Sciences, Mar 2024. URL: https://doi.org/10.3390/ijms25073835, doi:10.3390/ijms25073835. This article has 53 citations and is from a poor quality or predatory journal.
(song2025cellwallcomponents pages 18-19): Xiumei Song, Han Zhou, and Jingwen Wang. Cell wall components of gut commensal bacteria stimulate peritrophic matrix formation in malaria vector mosquitoes through activation of the imd pathway. PLOS Biology, 23:e3002967, Jan 2025. URL: https://doi.org/10.1371/journal.pbio.3002967, doi:10.1371/journal.pbio.3002967. This article has 7 citations and is from a highest quality peer-reviewed journal.
(meister2009anophelesgambiaepgrplcmediated pages 4-5): Stephan Meister, Bogos Agianian, Fanny Turlure, Angela Relógio, Isabelle Morlais, Fotis C. Kafatos, and George K. Christophides. Anopheles gambiae pgrplc-mediated defense against bacteria modulates infections with malaria parasites. PLoS Pathogens, 5:e1000542, Aug 2009. URL: https://doi.org/10.1371/journal.ppat.1000542, doi:10.1371/journal.ppat.1000542. This article has 290 citations and is from a highest quality peer-reviewed journal.
(meister2009anophelesgambiaepgrplcmediated pages 9-10): Stephan Meister, Bogos Agianian, Fanny Turlure, Angela Relógio, Isabelle Morlais, Fotis C. Kafatos, and George K. Christophides. Anopheles gambiae pgrplc-mediated defense against bacteria modulates infections with malaria parasites. PLoS Pathogens, 5:e1000542, Aug 2009. URL: https://doi.org/10.1371/journal.ppat.1000542, doi:10.1371/journal.ppat.1000542. This article has 290 citations and is from a highest quality peer-reviewed journal.
Gene: PGRPLC (Anopheles gambiae, UniProt A7UTA1)
Hypothesis: PGRPLC has N-acetylmuramoyl-L-alanine amidase activity (GO:0008745)
Evidence type: IBA (Inferred from Biological Aspect of Ancestor), GO_REF:0000033
Verdict: Over-annotated — annotation should be removed
Verdict: Over-annotated. The annotation of N-acetylmuramoyl-L-alanine amidase activity (GO:0008745) on Anopheles gambiae PGRPLC (UniProt A7UTA1) is not supported by sequence, structural, or functional evidence and should be removed. This annotation was propagated via phylogenetic inference (IBA, GO_REF:0000033) but is contradicted by three independent and convergent lines of evidence: (1) sequence analysis demonstrating loss of two of three essential zinc-coordinating catalytic residues, (2) high-confidence AlphaFold structural modeling confirming a disrupted active site incapable of zinc coordination, and (3) primary literature unambiguously establishing PGRP-LC orthologs as non-catalytic pattern recognition receptors that activate innate immune signaling. The IBA annotation represents a case of phylogenetic over-propagation from the ancestral PGRP amidase fold to a receptor subfamily that universally lost catalytic capacity early in its evolutionary divergence.
Key caveat: No direct biochemical assay of Ag PGRPLC amidase activity has been published. The verdict rests on strong negative computational evidence (missing catalytic residues in sequence and 3D structure, confirmed across all six PGRP-LC orthologs examined) combined with positive evidence for an alternative function (receptor activity, confirmed in the direct organism). The computational evidence alone is sufficient for a curation decision given its completeness and internal consistency.
The seed hypothesis proposes that Anopheles gambiae PGRPLC (A7UTA1) possesses N-acetylmuramoyl-L-alanine amidase activity (GO:0008745), an enzymatic function that cleaves the amide bond between N-acetylmuramic acid and L-alanine in bacterial peptidoglycan. This annotation was assigned via Inferred by Biological Aspect of Ancestor (IBA) evidence, meaning it was computationally propagated based on phylogenetic relatedness to other PGRP family members — some of which are indeed bona fide amidases (e.g., PGRP-LB, PGRP-SC1a/b, PGRP-SB1).
Our investigation systematically tested this hypothesis through catalytic residue analysis, AlphaFold structural modeling, cross-species conservation surveys across the PGRP-LC subfamily, and comprehensive literature review spanning 14 publications. We found that PGRPLC lacks two of the three zinc-binding residues absolutely required for amidase catalysis: the first zinc-ligand histidine is replaced by alanine (H→A at position 310), and the third zinc-ligand cysteine is replaced by serine (C→S at position 429). The AlphaFold model AF-A7UTA1-F1 (version 6) confirms these substitutions at very high confidence (pLDDT 96–99) and shows the spatial geometry is consistent with a vestigial, non-functional zinc-binding pocket — the fold is preserved for peptidoglycan binding, but the catalytic machinery is disrupted. This catalytic residue loss is universal across all six PGRP-LC orthologs examined from three insect species (Drosophila melanogaster, Anopheles gambiae, and Bombus species), representing two insect orders (Diptera and Hymenoptera), confirming that PGRP-LC is a dedicated non-catalytic receptor subfamily.
The primary literature unambiguously characterizes PGRP-LC as a transmembrane pattern recognition receptor that activates the Imd/NF-κB innate immune signaling pathway upon binding DAP-type peptidoglycan — it senses the ligand and transduces a signal rather than cleaving the ligand. Multiple studies explicitly distinguish "recognition PGRPs" (including PGRP-LC) from "catalytic PGRPs" (such as PGRP-LB). Notably, the well-characterized Drosophila ortholog (Q9GNK5) correctly lacks the GO:0008745 annotation in UniProt/FlyBase and instead carries experimentally derived annotations for peptidoglycan binding (GO:0042834, IDA) and peptidoglycan immune receptor activity (GO:0016019, IMP). The annotation on A7UTA1 is therefore inconsistent with the ortholog curation.
N-acetylmuramoyl-L-alanine amidase activity in the PGRP family requires a zinc-dependent catalytic mechanism with three essential zinc-coordinating residues: two histidines and one cysteine, forming the zinc triad that positions the catalytic water for amide bond hydrolysis. Multiple sequence alignment of Ag PGRPLC (A7UTA1) against five confirmed catalytic PGRPs revealed that PGRPLC has lost two of these three residues:
First zinc ligand His → Ala: At the conserved HH motif position, Ag PGRPLC has the sequence "VIIIAHT" where catalytic PGRPs have "YVIIHH", "YAIIHH", or "FLYVHH". The first histidine, which contributes an imidazole nitrogen for zinc coordination, is replaced by alanine — a small hydrophobic residue with no metal-coordinating capacity whatsoever.
Third zinc ligand Cys → Ser: The cysteine residue that completes the zinc coordination triad, consistently found in the CPG motif (ECPG or SCPG) of catalytic PGRPs upstream of the conserved WPH signature, is replaced by serine. No cysteine was found anywhere in the 25-residue region upstream of the WPH motif in PGRPLC. Cysteine's thiol group is critical for zinc coordination; serine's hydroxyl group is a far weaker zinc ligand (log K_a difference of ~3–4 orders of magnitude).
Conserved but insufficient residues: The catalytic tyrosine (Y347) and the second zinc-binding histidine (H421) are conserved in PGRPLC, but these alone cannot support zinc coordination or catalysis. This pattern — partial conservation of the catalytic apparatus — is the hallmark of a protein that retains the PGRP structural fold for ligand recognition while having lost enzymatic function. The catalytic residue substitution pattern in PGRPLC matches exactly the pattern in other confirmed non-catalytic receptor PGRPs (Dm PGRP-LC, Dm PGRP-SA, Dm PGRP-LE).
Mutagenesis studies on the related zinc-dependent amidase AmpD from Citrobacter freundii (PMID: 14507260) confirmed that mutation of zinc-ligand histidine to alanine (H34A) abolishes both enzymatic activity and zinc binding, establishing the biochemical framework for interpreting the natural H→A substitution in PGRPLC.
{{figure:pgrp_catalytic_residues.png|caption=Catalytic residue conservation analysis across PGRP family members. Ag PGRPLC (A7UTA1) lacks two of three zinc-coordinating residues (His→Ala and Cys→Ser substitutions) compared to confirmed catalytic PGRPs (PGRP-LB, PGRP-SC1a/b, PGRP-SB1, PGLYRP2). The conserved Tyr and second His are necessary but not sufficient for catalysis.}}
As a critical validation check, we examined the GO annotations of the best-characterized PGRP-LC ortholog, Drosophila melanogaster PGRP-LC (UniProt Q9GNK5). This protein has multiple experimentally-derived GO annotations including:
Critically, GO:0008745 (amidase activity) is NOT annotated for Dm PGRP-LC, despite this being the most extensively studied PGRP-LC ortholog with decades of experimental characterization. Computational verification confirmed that Q9GNK5 also lacks the HH motif and the catalytic Cys. This creates an inconsistency in the GO database: the IBA pipeline assigned amidase activity to the Anopheles ortholog while the Drosophila ortholog — which has far superior experimental annotation — correctly lacks this term. This inconsistency strongly supports the conclusion that the IBA annotation on A7UTA1 is erroneous.
Analysis of the AlphaFold model AF-A7UTA1-F1 (version 6) provided three-dimensional structural confirmation of the disrupted active site. All residues at the putative active-site positions were modeled with very high confidence (pLDDT >96), meaning the structural predictions are reliable:
| Position | Residue | Expected (catalytic) | pLDDT | Status |
|---|---|---|---|---|
| 310 | ALA | His (Zn ligand 1) | 98.5 | Substituted — no imidazole nitrogen |
| 311 | HIS | His (structural) | 98.6 | Present |
| 347 | TYR | Tyr (catalytic) | 98.6 | Present |
| 421 | HIS | His (Zn ligand 2) | 96.0 | Present |
| 429 | SER | Cys (Zn ligand 3) | 97.2 | Substituted — hydroxyl too weak |
Inter-residue distance measurements at the vestigial zinc-binding pocket:
| Atom Pair | Distance (Å) | Interpretation |
|---|---|---|
| A310.CB — S429.OG | 3.6 | Substituted ligands in vestigial pocket geometry |
| H311.NE2 — S429.OG | 4.1 | Near expected zinc coordination distance |
| H421.NE2 — S429.OG | 5.7 | Consistent with vestigial zinc site |
| H311.NE2 — H421.NE2 | 9.4 | Typical for zinc amidase fold |
The spatial arrangement is consistent with a vestigial zinc-binding pocket — the overall fold is maintained (important for peptidoglycan recognition), but the critical chemical groups for zinc coordination are absent. Alanine lacks an imidazole nitrogen entirely, and serine's hydroxyl is thermodynamically and kinetically inadequate to substitute for cysteine's thiol in zinc coordination. The combination makes zinc binding — and therefore zinc-dependent amidase catalysis — impossible.
A cross-species survey of PGRP-LC orthologs from three insect species demonstrated that the loss of catalytic residues is a universal, subfamily-defining feature — not an organism-specific anomaly in Anopheles:
| Protein | Species | Order | HH Motif | CPG Cys | Classification |
|---|---|---|---|---|---|
| PGRPLC (A7UTA1) | A. gambiae | Diptera | AH (no HH) | Ser (no Cys) | Non-catalytic |
| PGRP-LC-x (Q9GNK5) | D. melanogaster | Diptera | xH (no HH) | absent | Non-catalytic |
| PGRP-LC-a (Q9GNK5) | D. melanogaster | Diptera | xH (no HH) | absent | Non-catalytic |
| PGRP-LC-y (Q9GNK5) | D. melanogaster | Diptera | SH (no HH) | absent | Non-catalytic |
| PGRP-LC-1 | Bombus sp. | Hymenoptera | xH (no HH) | absent | Non-catalytic |
| PGRP-LC-2 | Bombus sp. | Hymenoptera | xH (no HH) | absent | Non-catalytic |
In contrast, all four confirmed catalytic PGRPs tested retained both diagnostic features:
| Protein | Species | HH Motif | CPG Cys | Classification |
|---|---|---|---|---|
| PGRP-LB (Q8INK6) | D. melanogaster | IIHHSY | ECPG | Catalytic |
| PGRP-SC1a (C0HK98) | D. melanogaster | AIIHHT | SCPG | Catalytic |
| PGRP-SC1b (C0HK99) | D. melanogaster | VIIHHSD | SCPG | Catalytic |
| PGRP-SB1 (Q70PY2) | D. melanogaster | present | present | Catalytic |
The 0/6 vs 4/4 split (non-catalytic PGRP-LC vs catalytic PGRPs) is perfectly concordant and spans two insect orders, providing strong evidence that catalytic residue loss occurred early in the evolutionary divergence of the PGRP-LC subfamily as a dedicated signaling receptor. The amidase annotation on any PGRP-LC ortholog is therefore a systematic over-annotation.
{{figure:final_evidence_figure.png|caption=Comprehensive evidence for PGRPLC non-catalytic classification. Left: disrupted active-site residues (Ala replaces zinc-ligand His, Ser replaces zinc-ligand Cys). Center: AlphaFold 3D geometry of the vestigial zinc pocket (AF-A7UTA1-F1, pLDDT >96). Right: cross-species classification showing all 6 PGRP-LC orthologs are universally non-catalytic while all 4 catalytic PGRPs retain the complete zinc triad.}}
| # | Citation | Evidence Type | Direction | Claim Tested | Key Finding | Context | Confidence |
|---|---|---|---|---|---|---|---|
| 1 | This study | Computational (active-site residue analysis) | Refutes amidase | PGRPLC has catalytic zinc triad | First zinc ligand His→Ala (pos 310); third zinc ligand Cys→Ser (pos 429); 2/3 zinc ligands lost | MSA of 7 PGRPs | High |
| 2 | This study | Computational (AlphaFold structure) | Refutes amidase | Active site is structurally intact | AF-A7UTA1-F1 shows vestigial zinc pocket with chemically incompetent ligands; all pLDDT >96 | 3D structural analysis | High |
| 3 | This study | Computational (cross-species survey) | Refutes amidase | Loss is PGRPLC-specific | All 6/6 PGRP-LC orthologs lack HH + CPG; 4/4 catalytic PGRPs retain both; universal subfamily feature | UniProt survey, 3 species, 2 orders | High |
| 4 | PMID: 19662170 | Mutant phenotype / functional | Supports receptor function | PGRPLC function in A. gambiae | "the transmembrane PGN Recognition Protein LC (PGRP-LC) is a receptor of the Imd signaling pathway that is activated after infection with bacteria" | A. gambiae, in vivo | High — direct study of this gene |
| 5 | PMID: 15657141 | Functional assay | Supports receptor function | Dm PGRP-LC molecular function | "PGRP-LC, a transmembrane protein required for the response to bacterial infection, acts at the top of a cytoplasmic signaling cascade" | D. melanogaster, in vivo | High — direct ortholog |
| 6 | PMID: 16556841 | Structural (crystal, 2.1 Å) | Supports binding, refutes catalysis | PGRP-LC binding mode | Crystal structure of TCT-PGRP-LCa/LCx complex shows ligand binding and receptor dimerization, no cleavage | D. melanogaster, in vitro | High — atomic resolution |
| 7 | PMID: 22118526 | Genetic/functional | Qualifies (distinguishes classes) | Catalytic vs. recognition PGRPs | "recognition PGRPs, which activate the Toll and Imd pathways" vs "six catalytic PGRPs with the capacity to scavenge peptidoglycan" | D. melanogaster, systematic analysis | High |
| 8 | PMID: 16618604 | Direct assay, comparison | Qualifies (contrasts functions) | PGRP-LB vs PGRP-LC | "host defense against gram-negative bacteria is mediated by the Imd pathway upon sensing of peptidoglycan by PGRP-LC. Here we report ... PGRP-LB, a catalytic member of the PGRP family" | D. melanogaster, biochemical assay | High |
| 9 | PMID: 17363965 | Review (synthesized evidence) | Qualifies | PGRP family diversity | "only some PGRPs have the catalytic activity...most PGRPs have diversified to carry out other host-defence functions" | Cross-species review | High — authoritative |
| 10 | PMID: 34066955 | Structural/review | Qualifies | PGRP catalytic mechanism | "Non-catalytic PGRPs are involved in the activation of immune pathways by binding to the PGN, whereas amidase PGRPs are capable of cleaving the PGN" | General, structural | High |
| 11 | PMID: 14507260 | Mutagenesis, enzymology | Supports residue framework | Zinc ligand requirements | H34A mutation in AmpD (a bona fide amidase) abolishes activity and zinc binding | C. freundii, in vitro | High |
| 12 | UniProt Q9GNK5 | Database (expert-curated) | Supports removal | Ortholog annotation state | Dm PGRP-LC has GO:0042834 (IDA) and GO:0016019 (IMP) but NOT GO:0008745 | FlyBase/UniProt curation | High |
The current annotation of GO:0008745 (N-acetylmuramoyl-L-alanine amidase activity) with IBA evidence should be removed from A7UTA1. This is a high-confidence lead based on convergent computational and literature evidence.
Rationale:
1. The protein lacks 2/3 zinc-binding residues essential for amidase catalysis (His→Ala, Cys→Ser)
2. The Drosophila ortholog Q9GNK5, with superior experimental characterization, does NOT carry this annotation
3. Multiple primary publications classify PGRP-LC explicitly as a non-catalytic pattern recognition receptor
4. The loss is universal across the PGRP-LC subfamily (6/6 orthologs from 2 insect orders)
5. AlphaFold structural analysis confirms the active site is chemically incapable of zinc coordination
| GO Term | Label | Ontology | Suggested Evidence | Justification |
|---|---|---|---|---|
| GO:0042834 | peptidoglycan binding | MF | IBA or ISS (from Q9GNK5) | Conserved PGRP fold retains PGN-binding capacity; Dm ortholog has IDA |
| GO:0016019 | peptidoglycan immune receptor activity | MF | IBA or ISS (from Q9GNK5), or IMP citing PMID:19662170 | Confirmed for Ag PGRPLC (PMID: 19662170) and Dm PGRP-LC (IMP) |
| GO:0004888 | transmembrane signaling receptor activity | MF | ISS | Supported by transmembrane topology and signal transduction function |
The IBA evidence code is appropriate for propagating conserved functions across orthologs, but it requires that the function being propagated is actually conserved — including conservation of the mechanistic basis for that function. In this case, the catalytic residues are not conserved, so IBA propagation of the catalytic activity is incorrect even though the overall PGRP domain fold is conserved. This is an instance of a known limitation of phylogenetic annotation transfer that occurs when binding and catalytic functions have diverged within a protein family.
PGRPLC functions as a transmembrane pattern recognition receptor for bacterial peptidoglycan, specifically DAP-type peptidoglycan found in Gram-negative bacteria. Its PGRP domain retains the structural fold necessary to bind peptidoglycan but has lost the zinc-dependent catalytic apparatus required to cleave it. Upon binding peptidoglycan, PGRPLC undergoes conformational changes (likely involving homo- or hetero-dimerization, as demonstrated for the Drosophila ortholog in the crystal structure study by Chang et al.) that activate the intracellular Imd signaling cascade, ultimately leading to NF-κB/Relish-dependent transcription of antimicrobial peptide genes.
This distinction is critical for GO annotation. The PGRP family has diverged into two functionally distinct groups that perform opposite biological roles:
PGRP Family (common ancestor: zinc-dependent amidase)
│
├── Catalytic PGRPs (amidases): PGRP-LB, PGRP-SC1a/b, PGRP-SB1, PGLYRP2
│ ├── Retain HH + CPG zinc triad → bind zinc → cleave PGN
│ ├── Cleave PGN → non-immunogenic fragments
│ └── Function: IMMUNE DAMPENING / negative regulation
│
└── Non-catalytic PGRPs (receptors): PGRP-LC, PGRP-LE, PGRP-SA, PGRP-SD
├── Lost 2/3 zinc ligands (H→A/S, C→S) → no zinc → no cleavage
├── Bind PGN intact → receptor dimerization → signal transduction
└── Function: IMMUNE ACTIVATION via Toll or Imd pathways
The amidase annotation conflates these two fundamentally different biological roles. Catalytic PGRPs act as negative regulators of immunity by degrading the immunostimulatory ligand, while receptor PGRPs like PGRPLC act as positive activators by sensing the ligand and transducing a signal. Assigning amidase activity to PGRPLC therefore not only misrepresents the molecular function but inverts the biological logic of its immune role.
The following are downstream consequences of PGRPLC's receptor function, not its direct molecular activity — they should not be confused with the MF annotation:
The IBA evidence code, assigned via GO_REF:0000033 (phylogenetic annotation by GO_Central using PANTHER), infers function from evolutionary relationships. All PGRPs share the Amidase_2 domain fold (Pfam PF01510) and are homologous to T7 lysozyme and bacterial amidases. The phylogenetic inference correctly identifies PGRPLC as a member of the PGRP family but incorrectly infers that the ancestral amidase activity is retained. This is a classic case of subfamily over-annotation where a shared domain fold does not equate to shared enzymatic function — analogous to pseudokinases that retain the kinase fold but lack phosphotransferase activity.
We found no evidence in the primary literature or any database suggesting that any PGRP-LC ortholog has amidase activity. No biochemical assay demonstrating peptidoglycan cleavage by any PGRP-LC has ever been published. Every characterization of PGRP-LC molecular function in the literature describes receptor and binding activities exclusively.
One theoretical alternative is that PGRPLC might bind zinc through a non-canonical coordination mechanism. However, this is unlikely because: (1) alanine has no metal-coordinating side chain, (2) serine is thermodynamically inadequate as a zinc ligand compared to cysteine, and (3) no alternative zinc-coordinating residues are positioned appropriately in the AlphaFold model. Even if trace zinc binding occurred, it would not be sufficient for catalysis without the complete coordination geometry.
The primary literature on PGRPLC function specifically in Anopheles gambiae (PMID: 19662170) directly confirms the receptor function and provides no evidence for amidase activity. There is no organism-specific divergence that would rescue catalytic activity lost at the sequence level. The mosquito and fly PGRP-LC orthologs share the same substitution pattern and functional characterization.
InterPro annotates A7UTA1 with IPR002502 (N-acetylmuramoyl-L-alanine amidase domain). This describes the structural fold, not the enzymatic activity. The distinction between a domain annotation (structural classification) and a GO molecular function annotation (biochemical activity) is important: many protein families retain domain folds while losing specific catalytic activities. The InterPro domain annotation is technically correct (PGRPLC has the amidase fold); the GO function annotation is not (PGRPLC does not perform the amidase reaction).
| # | Gap | What Was Checked | Why It Matters | What Would Resolve It |
|---|---|---|---|---|
| 1 | No direct biochemical amidase assay for A7UTA1 | PubMed literature search; no published enzymatic assay found | A negative enzymatic result would provide definitive IDA-level evidence for removal | Recombinant expression of PGRPLC ectodomain + PGN hydrolysis assay (HPLC muropeptide profiling) |
| 2 | No experimental crystal structure of Ag PGRPLC | AlphaFold model analyzed (AF-A7UTA1-F1, pLDDT >96 at all active-site positions) | Experimental structure would be definitive; AlphaFold prediction is high-confidence but not experimental | X-ray crystallography of PGRPLC ectodomain ± PGN fragment |
| 3 | Zinc binding not directly tested | 2/3 zinc ligands missing by sequence; AlphaFold distances measured | Even if amidase activity is absent, zinc-binding status affects GO:0008270 annotation | ICP-MS, PAR assay, or anomalous diffraction on purified protein |
| 4 | IBA pipeline propagation logic not traced | PANTHER tree node not examined | Understanding the source of the error could prevent similar over-annotations | Review PTHR11022 PANTHER tree ancestral reconstruction for amidase activity |
| 5 | Peptidoglycan binding confirmed only by homology for Ag PGRPLC | Crystal structure exists for Dm ortholog (PMID:16556841); no direct binding data for Ag | Replacement annotation (GO:0042834) should ideally have experimental support in this organism | SPR or pull-down assay with DAP-type PGN |
Peptidoglycan hydrolysis assay (definitive): Express and purify the PGRPLC ectodomain (approximately residues 242–464), and test for N-acetylmuramoyl-L-alanine amidase activity using HPLC-based muropeptide profiling with DAP-type PGN as substrate. Include Dm PGRP-LB as a positive control and heat-inactivated PGRP-LB as a negative control. A negative result would provide definitive IDA evidence for annotation removal.
Zinc-binding assay: Use ICP-MS or a colorimetric zinc assay (PAR assay) on purified PGRPLC PGRP domain to determine whether the disrupted triad retains any zinc-binding capacity. This directly tests the structural prediction.
Gain-of-function mutagenesis: Introduce the two missing zinc ligands (A310H, S429C) into PGRPLC and test whether this restores amidase activity. A positive result would definitively prove these substitutions are responsible for loss of catalysis.
Expanded PGRP-LC subfamily survey: Extend the cross-species analysis to additional insect orders (Lepidoptera, Coleoptera, Hemiptera) to confirm universal catalytic residue loss in the PGRP-LC clade and identify the evolutionary branch point where loss occurred.
Systematic IBA audit: Search the GO database for all proteins annotated with GO:0008745 via IBA and check whether each has the complete zinc triad. This would identify other potential over-annotations in the PGRP family.
Molecular dynamics simulation: Simulate the PGRPLC active site with and without zinc ion placement to assess whether the disrupted triad can transiently coordinate zinc under physiological conditions.
Meister et al. (2009) (PMID: 19662170) is the most directly relevant publication, examining PGRPLC function specifically in Anopheles gambiae. The authors describe PGRP-LC as "a receptor of the Imd signaling pathway that is activated after infection with bacteria," establishing its role as a sensor/receptor in the exact organism under review. The study demonstrates that PGRPLC-mediated defense modulates Plasmodium infection, connecting innate immune signaling to malaria vector competence.
Choe et al. (2005) (PMID: 15657141) characterizes Drosophila PGRP-LC as a protein that "acts at the top of a cytoplasmic signaling cascade," functioning as a signal-transducing innate immune receptor. This foundational study establishes PGRP-LC as a receptor, not an enzyme.
Chang et al. (2006) (PMID: 16556841) provides the crystal structure of tracheal cytotoxin (a monomeric PGN fragment) in complex with the PGRP-LCa/LCx ectodomain heterodimer at 2.1 Å resolution. This atomic-level structural data shows PGRP-LC binds peptidoglycan and triggers receptor dimerization, with no evidence of substrate cleavage — consistent with receptor function.
Zaidman-Rémy et al. (2006) (PMID: 16618604) directly contrasts PGRP-LC with PGRP-LB within a single study: "host defense against gram-negative bacteria is mediated by the Imd pathway upon sensing of peptidoglycan by PGRP-LC. Here we report a functional analysis of PGRP-LB, a catalytic member of the PGRP family." This explicit side-by-side comparison — PGRP-LC as sensor, PGRP-LB as catalyst — provides strong qualitative evidence.
Paredes et al. (2011) (PMID: 22118526) systematically categorizes PGRPs: "recognition PGRPs, which activate the Toll and Imd pathways" versus "six catalytic PGRPs with the capacity to scavenge peptidoglycan." PGRP-LC is explicitly placed in the recognition (non-catalytic) category.
Dziarski and Gupta (2006) (PMID: 17363965) provides an authoritative review: "only some PGRPs have the catalytic activity that protects the host from excessive inflammation, and most PGRPs have diversified to carry out other host-defence functions."
Kerff et al. (2003) (PMID: 14507260) — Mutagenesis of Citrobacter freundii AmpD, a zinc-dependent amidase in the same structural family as PGRPs, demonstrated that mutation of zinc ligands (H34A, D164A) abolishes both enzymatic activity and zinc binding. This establishes the biochemical requirement for intact zinc-coordinating residues — the same residues that PGRPLC naturally lacks.
Brisset et al. (2021) (PMID: 34066955) — Structural analysis of PGRP-LB amidase mechanism confirms the functional dichotomy: "Non-catalytic PGRPs are involved in the activation of immune pathways by binding to the PGN, whereas amidase PGRPs are capable of cleaving the PGN into non-immunogenic compounds."
Paquette et al. (2017) (PMID: 29045898) describes PGRP-LC and PGRP-LE as receptors that activate the Imd pathway through amyloid-like aggregation of the adaptor protein Imd, providing additional mechanistic detail on the receptor signaling mechanism that is the true function of these proteins.
Lhocine et al. (2008) (PMID: 18688280) identifies Rudra as a negative regulator that binds and inhibits PGRP-LC, further confirming its role as a signaling receptor requiring regulation.
No direct biochemical assay of Ag PGRPLC amidase activity: Our conclusion is based on computational analysis (sequence, structure, conservation) and analogy to the well-characterized Drosophila ortholog. While the convergent evidence is overwhelming, it remains formally indirect — no one has demonstrated in vitro that purified PGRPLC cannot cleave PGN.
AlphaFold model rather than experimental structure: The structural analysis relies on a predicted model. However, the very high pLDDT scores (>96 for all active-site residues) and complete consistency with the sequence analysis provide strong confidence. The Drosophila PGRP-LC crystal structure (PMID: 16556841) corroborates the predicted fold.
Cross-species survey limited to 3 insect species: The conservation survey covered 6 PGRP-LC sequences from Drosophila, Anopheles, and Bombus (2 insect orders). A broader survey across additional orders would strengthen the universality claim, though the complete concordance observed (0/6 catalytic) spanning 2 orders is already highly informative.
IBA pipeline internals not audited: We could not directly examine the PANTHER ancestral reconstruction to determine exactly how GO:0008745 was assigned to A7UTA1. The specific phylogenetic node and inference logic that led to this over-propagation remain unclear.
Replacement annotations based on ortholog inference: The recommended replacement terms (GO:0042834, GO:0016019) for Ag PGRPLC are based primarily on ISS/IBA from the Drosophila ortholog. Direct experimental evidence in A. gambiae for peptidoglycan binding (IDA-level) is limited to functional studies rather than direct binding assays.
{{figure:pgrp_evidence_summary.png|caption=Summary evidence figure integrating sequence analysis, structural modeling, and literature evidence supporting the over-annotation verdict for GO:0008745 on Ag PGRPLC}}
id: A7UTA1
gene_symbol: PGRPLC
product_type: PROTEIN
status: DRAFT
taxon:
id: NCBITaxon:7165
label: Anopheles gambiae
description: >
PGRPLC (AGAP005203) is a transmembrane peptidoglycan recognition protein (PGRP) that serves as the
principal upstream receptor for the IMD (Immune Deficiency) signaling pathway in Anopheles gambiae.
It is the ortholog of Drosophila PGRP-LC. Despite containing an amidase_2 superfamily domain,
PGRPLC functions as a NON-CATALYTIC pattern recognition receptor that binds DAP-type peptidoglycan
from bacterial cell walls to initiate innate immune signaling. Three main isoforms (LC1, LC2, LC3)
arise from alternative splicing and show distinct ligand binding properties: LC1 and LC3 bind
polymeric DAP-PGN, while LC2 forms complexes with LC3 in the presence of monomeric TCT muropeptides.
PGRPLC-mediated activation of the REL2/NF-kB pathway induces antimicrobial peptide expression,
controls gut microbiota homeostasis, and indirectly modulates Plasmodium infection intensity in
this malaria vector species.
existing_annotations:
- term:
id: GO:0005615
label: extracellular space
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >
The IBA annotation for extracellular space is propagated from Drosophila PGRP-LC orthologs
and human PGRPs. However, Anopheles PGRPLC is a transmembrane receptor with a single
transmembrane helix (residues 218-241 per UniProt) and the PGRP domain is located
C-terminal to this transmembrane region, indicating the receptor domain faces extracellularly.
The protein is membrane-anchored, not secreted into the extracellular space.
action: MODIFY
reason: >
PGRPLC is a type I transmembrane protein based on UniProt domain annotation showing
a transmembrane helix at positions 218-241 and the PGRP domain at 280-425. The deep
research (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md) confirms it is localized to the
"Epithelial plasma membrane of the midgut". The annotation should reflect plasma membrane
localization, not extracellular space which implies a secreted/soluble form.
proposed_replacement_terms:
- id: GO:0005886
label: plasma membrane
additional_reference_ids:
- file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
supported_by:
- reference_id: file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
supporting_text: "Functional analyses localize PGRPLC activity to the midgut epithelium with regionalized expression"
- term:
id: GO:0006955
label: immune response
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >
PGRPLC is firmly established as an immune receptor that initiates the innate immune
response against bacterial pathogens in Anopheles gambiae. RNAi knockdown experiments
demonstrate increased mortality upon bacterial challenge and impaired antimicrobial
peptide induction (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md).
action: ACCEPT
reason: >
This is a well-supported core function. The deep research establishes that PGRPLC
knockdown "decreased survival - E. coli, 50% mortality by day 4; S. aureus, 50% by
day 2 and near-complete by day 6" and impairs AMP induction. The term 'immune response'
accurately captures the general biological process.
supported_by:
- reference_id: file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
supporting_text: "Systemic antibacterial challenge survival (RNAi PGRPLC): Whole-gene KD decreased survival - E. coli, 50% mortality by day 4; S. aureus, 50% by day 2 and near-complete by day 6 (both P<0.001)"
- term:
id: GO:0008745
label: N-acetylmuramoyl-L-alanine amidase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >
This is an OVER-ANNOTATION. While PGRPLC contains an amidase_2 superfamily domain
(IPR002502), the literature explicitly states that PGRP-LC functions as a non-catalytic
pattern recognition receptor in insects. The amidase fold is used for peptidoglycan
binding and receptor dimerization, NOT for enzymatic hydrolysis.
action: REMOVE
reason: >
The deep research (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md) explicitly states:
"Despite the amidase fold, PGRP-LC functions as a non-catalytic pattern-recognition
receptor in mosquitoes (structural alignment/modeling; no amidase activity reported)".
OpenScientist independently found that PGRPLC lacks two of the three zinc-binding residues
required for PGRP amidase catalysis (H310A and C429S relative to catalytic PGRPs). The
fetched GOA line shows live IBA propagation through PANTHER:PTN002475783 from a mixed PGRP
source set; this should not be retained for the non-catalytic receptor PGRP-LC subfamily.
The correct molecular function is peptidoglycan immune receptor activity (GO:0016019).
propagation_review:
root_cause: PROPAGATION_BAD
failure_modes:
- PSEUDO_OR_SUBACTIVITY_LOSS
- SOURCE_EVIDENCE_WEAK
source_entities:
- source_id: PANTHER:PTN002475783
source_label: PAINT PGRP amidase source node
source_status: SUPPORTS_SOURCE_BUT_NOT_TARGET
comment: The fetched GOA line propagates GO:0008745 through this node, but
PGRPLC is a non-catalytic PGRP-LC receptor and lacks the zinc-ligand
residue set needed for amidase catalysis.
supported_by:
- reference_id: file:ANOGA/PGRPLC/PGRPLC-goa.tsv
supporting_text: "UniProtKB\tA7UTA1\tPGRPLC\tenables\tGO:0008745\tN-acetylmuramoyl-L-alanine amidase activity\tmolecular_function\tECO:0000318\tIBA\tGO_REF:0000033\tFB:FBgn0033327|FB:FBgn0037906|FB:FBgn0043578|PANTHER:PTN002475783|UniProtKB:Q96PD5|ZFIN:ZDB-GENE-050419-71|ZFIN:ZDB-GENE-071227-1|ZFIN:ZDB-GENE-071227-2\t7165\tAnopheles gambiae\tGO_Central\tAGAP005203-PC\t20250731"
- reference_id: file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
supporting_text: "Despite the amidase fold, PGRP-LC functions as a non-catalytic pattern-recognition receptor in mosquitoes (structural alignment/modeling; no amidase activity reported)"
- reference_id: file:ANOGA/PGRPLC/PGRPLC-hypotheses/function-hypothesis-go-0008745/openscientist.md
supporting_text: PGRPLC lacks two of the three zinc-binding residues absolutely
required for amidase catalysis
- reference_id: file:ANOGA/PGRPLC/PGRPLC-hypotheses/function-hypothesis-go-0008745/openscientist.md
supporting_text: The current annotation of GO:0008745 (N-acetylmuramoyl-L-alanine
amidase activity) with IBA evidence should be **removed** from A7UTA1.
- term:
id: GO:0016019
label: peptidoglycan immune receptor activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >
This is the CORRECT and PRIMARY molecular function annotation for PGRPLC. It accurately
describes the protein as a peptidoglycan recognition receptor that initiates immune
signaling upon ligand binding.
action: ACCEPT
reason: >
The deep research (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md) confirms PGRPLC as
the "Transmembrane pattern-recognition receptor of the IMD/REL2 pathway" that "Recognizes
DAP-type PGN ligands in both polymeric (bacterial sacculus) and monomeric (TCT-like)
forms via isoform assemblies." Pull-down assays demonstrate direct peptidoglycan binding
by PGRPLC isoforms. This is the core molecular function term for this protein.
supported_by:
- reference_id: file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
supporting_text: "Ligand specificity: PGRPLC discriminates between polymeric DAP-type PGN and monomeric muropeptides (TCT). In pull-down assays, LC1 and LC3 bind insoluble polymeric DAP-PGN, while LC2 forms complexes with LC3 in the presence of TCT monomer"
- term:
id: GO:0050830
label: defense response to Gram-positive bacterium
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >
PGRPLC is primarily known as a receptor for DAP-type peptidoglycan, which is characteristic
of Gram-negative bacteria and Bacillus species. However, experimental evidence shows
PGRPLC-dependent survival and AMP induction against S. aureus (Gram-positive).
action: KEEP_AS_NON_CORE
reason: >
The deep research (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md) shows PGRPLC knockdown
causes mortality after S. aureus challenge: "S. aureus, 50% by day 2 and near-complete by
day 6." However, the primary recognized ligand is DAP-type PGN from Gram-negative bacteria.
Gram-positive bacteria like S. aureus contain Lys-type PGN, not DAP-type. The defense
response may be indirect or involve cross-reactivity. PGRPLC's canonical role is in sensing
Gram-negative bacteria through the IMD pathway. A more appropriate annotation would be
defense response to Gram-negative bacterium (GO:0050829), but the existing annotation is
not wrong as PGRPLC does contribute to Gram-positive defense.
supported_by:
- reference_id: file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
supporting_text: "Systemic antibacterial challenge survival: S. aureus, 50% by day 2 and near-complete by day 6 (both P<0.001)"
- term:
id: GO:0002376
label: immune system process
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >
This IEA annotation from UniProtKB keyword mapping is a broad parent term of the
more specific immune response annotation. It is not wrong but is less informative
than the existing IBA annotation for immune response.
action: ACCEPT
reason: >
The annotation is correct as PGRPLC participates in immune system processes.
However, the more specific 'immune response' (GO:0006955) annotation is preferred
for capturing the gene's function. This broader term can be retained as it does
not conflict and provides a valid hierarchical annotation.
supported_by:
- reference_id: file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
supporting_text: "PGRP-LC-driven sensing in the gut is particularly important for antibacterial defense"
- term:
id: GO:0008270
label: zinc ion binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >
This IEA annotation is based on InterPro domain IPR006619 (PGRP domain). The PGRP
domain structure in catalytic family members coordinates a zinc ion essential for
amidase activity. However, since PGRPLC is non-catalytic, the zinc binding function
may not be relevant.
action: UNDECIDED
reason: >
The InterPro PGRP domain annotation (IPR006619) suggests potential zinc binding based
on structural homology to catalytic PGRPs. However, the deep research
(file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md) explicitly states PGRPLC is
non-catalytic and "no amidase activity reported." Catalytic PGRPs require zinc for
amidase activity, but non-catalytic PGRPs may have lost critical zinc-coordinating
residues. Without specific structural data for Anopheles PGRPLC showing zinc coordination,
this annotation remains uncertain.
supported_by:
- reference_id: file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
supporting_text: "Despite the amidase fold, PGRP-LC functions as a non-catalytic pattern-recognition receptor"
- term:
id: GO:0008745
label: N-acetylmuramoyl-L-alanine amidase activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >
This is the same over-annotation as the IBA version, but derived from InterPro domain
mapping instead of phylogenetic inference. PGRPLC does NOT have amidase activity.
action: REMOVE
reason: >
Same rationale as for the IBA annotation above. The InterPro domains (IPR002502,
IPR006619, IPR036505) are structural domains that can be present in both catalytic
and non-catalytic PGRPs. PGRPLC uses this fold for peptidoglycan binding and receptor
function, NOT for enzymatic hydrolysis. The literature explicitly confirms this is
a non-catalytic receptor PGRP (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md).
supported_by:
- reference_id: file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
supporting_text: "It is not an active amidase enzyme; rather, it uses a PGRP/amidase_2 structural fold for ligand binding and receptor dimerization to initiate signaling"
- term:
id: GO:0009253
label: peptidoglycan catabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >
This annotation implies PGRPLC degrades peptidoglycan, which is incorrect. PGRPLC
binds peptidoglycan as a receptor ligand but does not catabolize it.
action: REMOVE
reason: >
This annotation is a logical consequence of the incorrect amidase activity annotation.
Since PGRPLC is a non-catalytic receptor, it does not participate in peptidoglycan
catabolism. It binds peptidoglycan to initiate signaling, but binding is not
catabolism. The correct process annotation is the peptidoglycan recognition protein
signaling pathway (GO:0061057) or immune response (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md).
supported_by:
- reference_id: file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
supporting_text: "It uses a PGRP/amidase_2 structural fold for ligand binding and receptor dimerization to initiate signaling"
- term:
id: GO:0045087
label: innate immune response
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >
This annotation accurately captures that PGRPLC functions in innate immunity.
It is more specific than 'immune system process' and appropriately describes
the non-adaptive immune function of this receptor.
action: ACCEPT
reason: >
The deep research (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md) and multiple
publications confirm PGRPLC as the canonical innate immune receptor for the IMD
pathway in mosquitoes. The term is appropriate and well-supported by experimental
evidence showing PGRPLC initiates innate immune responses including AMP production
and defense against bacteria.
supported_by:
- reference_id: file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
supporting_text: "PGRPLC is the principal transmembrane receptor that activates the mosquito IMD/REL2 NF-kB pathway, leading to induction of antimicrobial peptide (AMP) genes"
# New annotations not currently present that should be added based on evidence
- term:
id: GO:0061057
label: peptidoglycan recognition protein signaling pathway
evidence_type: TAS
original_reference_id: file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
review:
summary: >
PGRPLC is the initiating receptor for the peptidoglycan recognition protein (IMD)
signaling pathway. This is a missing core process annotation.
action: NEW
reason: >
The deep research (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md) explicitly states
PGRPLC is "Upstream PRR of the mosquito IMD pathway, activating REL2/NF-kB to induce AMPs."
The GO term GO:0061057 explicitly describes this pathway with definition: "The series of
molecular signals initiated by binding of peptidoglycan to a receptor and ending with
regulation of a downstream cellular process. The main outcome of the Imd signaling is
the production of antimicrobial peptides." This is the most specific and appropriate
process term for PGRPLC.
supported_by:
- reference_id: file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
supporting_text: "PGRPLC is the principal transmembrane receptor that activates the mosquito IMD/REL2 NF-kB pathway"
- term:
id: GO:0050829
label: defense response to Gram-negative bacterium
evidence_type: TAS
original_reference_id: file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
review:
summary: >
PGRPLC specifically recognizes DAP-type peptidoglycan, which is characteristic
of Gram-negative bacteria. This is the primary defense response mediated by PGRPLC.
action: NEW
reason: >
The deep research (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md) confirms "Substrate
specificity: Discriminates DAP-type PGN." DAP-type peptidoglycan is the signature cell
wall component of Gram-negative bacteria. PGRPLC knockdown increases susceptibility to
E. coli (Gram-negative) and also affects Plasmodium infection through gut microbiota
control (primarily Gram-negative in mosquito gut). This term complements the existing
Gram-positive annotation and is arguably more central to PGRPLC function.
supported_by:
- reference_id: file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
supporting_text: "Substrate specificity: Discriminates DAP-type PGN. LC1/LC3 bind polymeric DAP-PGN"
- term:
id: GO:0042834
label: peptidoglycan binding
evidence_type: IDA
original_reference_id: file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
review:
summary: >
Biochemical pull-down assays demonstrate direct binding of PGRPLC isoforms to
peptidoglycan ligands, supporting a peptidoglycan binding annotation.
action: NEW
reason: >
The deep research (file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md) reports:
"Biochemical ligand interactions: Co-precipitation shows LC1 and LC3 bind insoluble
polymeric DAP-type PGN; LC2 forms complexes with LC3 in the presence of the monomeric
muropeptide TCT." This is direct experimental evidence for peptidoglycan binding activity.
While peptidoglycan immune receptor activity (GO:0016019) encompasses this function,
peptidoglycan binding (GO:0042834) is an appropriate supporting annotation for the
binding activity itself.
supported_by:
- reference_id: file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
supporting_text: "Co-precipitation shows LC1 and LC3 bind insoluble polymeric DAP-type PGN; LC2 forms complexes with LC3 in the presence of the monomeric muropeptide TCT"
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: file:ANOGA/PGRPLC/PGRPLC-goa.tsv
title: GOA annotations for Anopheles gambiae PGRPLC
findings:
- statement: The fetched GOA line for the contested GO:0008745 IBA annotation
propagates amidase activity through PANTHER:PTN002475783 and a mixed PGRP
source set.
supporting_text: "UniProtKB\tA7UTA1\tPGRPLC\tenables\tGO:0008745\tN-acetylmuramoyl-L-alanine amidase activity\tmolecular_function\tECO:0000318\tIBA\tGO_REF:0000033\tFB:FBgn0033327|FB:FBgn0037906|FB:FBgn0043578|PANTHER:PTN002475783|UniProtKB:Q96PD5|ZFIN:ZDB-GENE-050419-71|ZFIN:ZDB-GENE-071227-1|ZFIN:ZDB-GENE-071227-2\t7165\tAnopheles gambiae\tGO_Central\tAGAP005203-PC\t20250731"
- id: file:ANOGA/PGRPLC/PGRPLC-hypotheses/function-hypothesis-go-0008745/openscientist.md
title: OpenScientist hypothesis investigation - PGRPLC amidase activity
publication_type: DEEP_RESEARCH
findings:
- statement: OpenScientist classified the GO:0008745 IBA amidase annotation
as over-annotated and recommended removal.
supporting_text: "Verdict: Over-annotated."
- statement: OpenScientist found that PGRPLC lacks two of the three zinc-binding
residues required for PGRP amidase catalysis.
supporting_text: PGRPLC lacks two of the three zinc-binding residues absolutely
required for amidase catalysis
- statement: OpenScientist recommended removing the IBA GO:0008745 annotation
from A7UTA1.
supporting_text: The current annotation of GO:0008745 (N-acetylmuramoyl-L-alanine
amidase activity) with IBA evidence should be **removed** from A7UTA1.
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: OpenScientist autonomous-compute report directly tests the contested
PGRPLC amidase assignment using PGRP catalytic-residue analysis and AlphaFold
structural provenance. This review uses the report's verified zinc-ligand-loss
and removal-recommendation snippets and anchors propagation metadata to the
local GOA source line for PANTHER:PTN002475783.
- id: GO_REF:0000043
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
findings: []
- id: file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
title: "Deep research summary for PGRPLC in Anopheles gambiae"
findings:
- statement: PGRPLC is the principal IMD pathway receptor in An. gambiae
supporting_text: "PGRPLC is the principal transmembrane receptor that activates the mosquito IMD/REL2 NF-kB pathway"
- statement: RNAi knockdown demonstrated role in antibacterial defense
supporting_text: "Systemic antibacterial challenge survival (RNAi PGRPLC): Whole-gene KD decreased survival - E. coli, 50% mortality by day 4"
- statement: PGRPLC is non-catalytic
supporting_text: "Despite the amidase fold, PGRP-LC functions as a non-catalytic pattern-recognition receptor in mosquitoes"
- statement: Three isoforms show distinct ligand binding properties
supporting_text: "LC1 and LC3 bind insoluble polymeric DAP-PGN, while LC2 forms complexes with LC3 in the presence of TCT monomer"
- statement: Located at midgut plasma membrane
supporting_text: "Functional analyses localize PGRPLC activity to the midgut epithelium with regionalized expression"
core_functions:
- description: >
PGRPLC is the principal transmembrane receptor for the IMD pathway.
It directly binds DAP-type peptidoglycan via the PGRP domain.
Three isoforms show distinct ligand binding properties.
Non-catalytic receptor function confirmed by structural analysis.
molecular_function:
id: GO:0016019
label: peptidoglycan immune receptor activity
directly_involved_in:
- id: GO:0061057
label: peptidoglycan recognition protein signaling pathway
locations:
- id: GO:0005886
label: plasma membrane
supported_by:
- reference_id: file:ANOGA/PGRPLC/PGRPLC-deep-research-falcon.md
supporting_text: "PGRP-LC is the principal transmembrane receptor that activates the mosquito IMD/REL2 NF-kB pathway"
proposed_new_terms: []
suggested_questions:
- question: Has the catalytic site residue status been experimentally verified for An. gambiae PGRPLC, confirming it lacks amidase activity?
- question: What is the three-dimensional structure of PGRPLC PGRP domain and how does it compare to catalytic vs non-catalytic PGRP structures?
- question: Does PGRPLC coordinate zinc, and if so, what is its functional role in ligand binding?
suggested_experiments:
- description: Recombinant expression and biochemical assay to definitively confirm absence of amidase activity
hypothesis: PGRPLC lacks amidase activity due to non-catalytic residues in the active site
- description: Crystal or cryo-EM structure determination of PGRPLC PGRP domain with and without PGN ligand
hypothesis: PGRPLC PGRP domain adopts receptor conformation distinct from catalytic PGRPs
- description: Metal binding analysis (ITC, ICP-MS) to determine zinc coordination status
hypothesis: PGRPLC may or may not coordinate zinc depending on retention of zinc-binding residues